Matthew S. Krantz

1.4k total citations · 1 hit paper
41 papers, 788 citations indexed

About

Matthew S. Krantz is a scholar working on Pharmacology, Immunology and Allergy and Dermatology. According to data from OpenAlex, Matthew S. Krantz has authored 41 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 11 papers in Immunology and Allergy and 10 papers in Dermatology. Recurrent topics in Matthew S. Krantz's work include Drug-Induced Adverse Reactions (25 papers), Food Allergy and Anaphylaxis Research (11 papers) and Contact Dermatitis and Allergies (9 papers). Matthew S. Krantz is often cited by papers focused on Drug-Induced Adverse Reactions (25 papers), Food Allergy and Anaphylaxis Research (11 papers) and Contact Dermatitis and Allergies (9 papers). Matthew S. Krantz collaborates with scholars based in United States, Australia and United Kingdom. Matthew S. Krantz's co-authors include Elizabeth J. Phillips, Cosby A. Stone, Andrew Abreo, Yiwei Liu, Roger Yu, Amanda Pratt, Jonathan A. Hemler, Mary V. Relling, Santiago Quirce and María Luisa Caballero and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Matthew S. Krantz

34 papers receiving 777 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized

2018 246 citations Cosby A. Stone, Yiwei Liu et al. The Journal of Allergy and Clinical Immunology In Practice profile →

Peers

Countries citing papers authored by Matthew S. Krantz

Since Specialization

Citations

This map shows the geographic impact of Matthew S. Krantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Krantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Krantz more than expected).

Fields of papers citing papers by Matthew S. Krantz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Krantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Krantz. The network helps show where Matthew S. Krantz may publish in the future.

Co-authorship network of co-authors of Matthew S. Krantz

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Krantz. A scholar is included among the top collaborators of Matthew S. Krantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Krantz. Matthew S. Krantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Food allergy clinical course in children and adolescents treated with dupilumab for atopic dermatitis 2025 ·Annals of Allergy Asthma & Immunology ·(unknown), Matthew S. Krantz, Rachel G. Robison	0
2	HLA-B58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US 2025 ·JAMA Dermatology* ·(unknown), Matthew S. Krantz, (unknown), Elizabeth J. P. Phillips, (unknown), (unknown), Aaron M. Drucker, Elizabeth Ergen, Rama Gangula, Michelle Goh, Benjamin H. Kaffenberger, Dana King, Rebecca Lee, (unknown), (unknown), Robert G. Micheletti, (unknown), (unknown), Suman Pakala, (unknown), Kristina Williams	0
3	Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS 2025 ·Toxicological Sciences ·Joshua Gardner, (unknown), (unknown), Paul Thomson, (unknown), Andrew Gibson, Matthew S. Krantz, Michael R. Ardern‐Jones, Elizabeth J. Phillips, Dean J. Naisbitt	0
4	Improving topic modeling performance on social media through semantic relationships within biomedical terminology 2025 ·PLoS ONE ·(unknown), (unknown), (unknown), Matthew S. Krantz, V. Eric Kerchberger, Alyson L. Dickson, QiPing Feng, Zhijun Yin, Wei-Qi Wei	1
5	Immune Checkpoint Inhibitors as Independent and Synergistic Drivers of SJS/TEN 2025 ·JAMA Oncology ·Eric Mukherjee, David S. Park, (unknown), Matthew S. Krantz, Cosby A. Stone, (unknown), Elizabeth Phillips	1
6	Direct oral challenges safely reduce the burden of low-risk cephalosporin allergy labels 2025 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), Rebecca Lee, Grace Koo, Matthew S. Krantz, (unknown), Elizabeth J. Phillips, Cosby A. Stone	1
7	The clinical application of genetic testing in DILI, are we there yet? 2024 ·Clinical Liver Disease ·Matthew S. Krantz, (unknown), Elizabeth J. Phillips	3
8	Glycolysis: An early marker for vancomycin‐specific T‐cell activation 2024 ·Clinical & Experimental Allergy ·Joshua Gardner, (unknown), Rebecca L. Jensen, Andrew Gibson, Matthew S. Krantz, Michael R. Ardern‐Jones, Elizabeth J. Phillips, Munir Pirmohamed, Amy E. Chadwick, Catherine J. Betts, Dean J. Naisbitt	3
9	Large language models facilitate the generation of electronic health record phenotyping algorithms 2024 ·Journal of the American Medical Informatics Association ·Chao Yan, Henry H. Ong, (unknown), Matthew S. Krantz, (unknown), Alyson L. Dickson, Josh F. Peterson, QiPing Feng, Dan M. Roden, C. Stein, V. Eric Kerchberger, Bradley Malin, Wei‐Qi Wei	10
10	Genetic and Epidemiologic Risk Associated with IgE-mediated Anaphylaxis to Polyethylene Glycol 2023 ·Journal of Allergy and Clinical Immunology ·Cosby A. Stone, Suman Pakala, (unknown), Matthew S. Krantz, (unknown), Elizabeth J. Phillips	1
11	Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions 2023 ·Journal of Allergy and Clinical Immunology ·Andrew Gibson, (unknown), (unknown), Matthew S. Krantz, Eric Mukherjee, Maja Mockenhaupt, Munir Pirmohamed, Amy M. Palubinsky, Elizabeth J. Phillips	42
12	Drug reaction with eosinophilia and systemic symptoms (DRESS) with dual sensitization to both vancomycin and ceftriaxone 2023 ·Journal of Allergy and Clinical Immunology ·Matthew S. Krantz, Andrew Gibson, Ramesh Ram, Rama Gangula, Fiona James, Natasha E. Holmes, Effie Mouhtouris, Suman Pakala, (unknown), (unknown), Jason A. Trubiano, Elizabeth J. Phillips	2
13	Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy 2022 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), Grace Koo, (unknown), (unknown), Matthew S. Krantz, (unknown), (unknown), Elizabeth J. Phillips, Cosby A. Stone, Lene H. Garvey	11
14	An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·Matthew S. Krantz, Cosby A. Stone, (unknown), (unknown), Grace Koo, (unknown), (unknown), (unknown), Emily M. Campbell, Elizabeth J. Phillips	7
15	Intradermal Skin Testing and Oral Challenge for Patients Labeled as Fluoroquinolone Allergic 2020 ·Journal of Allergy and Clinical Immunology ·Matthew S. Krantz, Cosby A. Stone, Roger Yu, (unknown), Elizabeth Phillips	1
16	Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS) 2020 ·The Journal of Allergy and Clinical Immunology In Practice ·Roger Yu, Matthew S. Krantz, Elizabeth J. Phillips, Cosby A. Stone	133
17	Exploring perioperative complications of anterior lumber interbody fusion in patients with a history of prior abdominal surgery: A retrospective cohort study 2020 ·The Spine Journal ·Arbaz Momin, Edward M. Barksdale, (unknown), (unknown), Amy S. Nowacki, Robert Winkelman, Matthew S. Krantz, David Hardy, Michael P. Steinmetz	20
18	Oral challenge with trimethoprim-sulfamethoxazole in patients with “sulfa” antibiotic allergy 2019 ·The Journal of Allergy and Clinical Immunology In Practice ·Matthew S. Krantz, Cosby A. Stone, Andrew Abreo, Elizabeth J. Phillips	39
19	Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized breakdown → 2018 ·The Journal of Allergy and Clinical Immunology In Practice ·Cosby A. Stone, Yiwei Liu, Mary V. Relling, Matthew S. Krantz, Amanda Pratt, Andrew Abreo, Jonathan A. Hemler, Elizabeth J. Phillips	246
20	Small ubiquitin‐like modifier 1–3 is activated in human astrocytic brain tumors and is required for glioblastoma cell survival 2012 ·Cancer Science ·Wei Yang, Liangli Wang, (unknown), Robert D. Pearlstein, Francis Ali‐Osman, Hongjie Pan, Roland Goldbrunner, Matthew S. Krantz, Christoph Harms, Wulf Paschen	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact